ID: MRFR/Pharma/5001-HCR | 100 Pages | Author: Rahul Gotadki | June 2023
The Bone Wax Market is projected to reach USD 61.68 Million by 2030 at 2.90% CAGR during the forecast period 2022-2030.
$61.68 Million
2.90%
North America
2022-2030
The bone wax market has been segmented into product, material, application, and end-user.
The market, on the basis of product, is segmented into absorbable bone wax and non-absorbable bone wax.
The market, by material, has been segmented into natural bone wax and synthetic bone wax.
The market, by application, has been segmented into neurosurgery, orthopedic surgery, thoracic surgery, oral surgery, and others.
On the basis of end-user, the market has been segmented into hospitals, clinical laboratories, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The bone wax market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European bone wax market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The bone wax market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The bone wax market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players
ABYRX, Inc., Wound Management Technologies, Inc., Aesculap, Inc., Ethicon, Inc., Medtronic Plc, Baxter International, Medline Industries, Inc., Futura Surgicare Pvt. Ltd., CP Medical Corp., Bentley Healthcare Pvt. Ltd., WNDW Medical Inc., GPC Medical Ltd., and others are some prominent players in the bone wax market.
Regional Market Summary
Global Bone Wax Market Share (%), by Region, 2017
Source: American Joint Replacement Registry, National Center for Biotechnology Information (NCBI), Annual reports
Geographically, the Americas is anticipated to dominate the bone wax market owing to a well-developed healthcare sector, rising number of surgeries, steady growing occurrence of orthopedic diseases, growing number of surgeries and relatively large number of research and development activities. According to an article published by the National Center for Biotechnology Information (NCBI) in 2016, osteoarthritis (OA) is affecting an estimated 12% of the US adults in the age group 25 to 74 years.
Europe is expected to hold the second largest position in the bone wax market. The market growth in this region is attributed to the rising prevalence of orthopedic disease, increasing occurrences of accidents and injuries, and increasing expenditure on the healthcare sector. According to the Eurostat, around 7.1 million in-patients with injuries, poisoning and other consequences such as accidents were discharged from hospitals in the European Union (EU) in 2015.
The bone wax market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is anticipated to be the fastest growing region in the market due to continuously developing economies, rising prevalence of bone diseases, an increasing number of geriatric populations, and increasing government funding for the healthcare sector. According to the report by the United Nations Department of Economic and Social Affairs, in India, the number of older persons is projected to grow by 64% between the years 2015 and 2030. It also projected that the number of older persons in China is projected to grow by 71% over the same period.
On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector, and the growing prevalence of bone disorders and growing government initiatives for the healthcare sector.
Bone Wax Market, by Product
Bone Wax Market, by Material
Bone Wax Market, by Application
Bone Wax Market, by End-User
Bone Wax Market, by Region
Recent Development
Intended Audience
Report Attribute/Metric | Details |
---|---|
Market Size | USD 61.68 Million |
CAGR | 2.90% |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product, Material, Application, and End-user. |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | ABYRX, Inc., Wound Management Technologies, Inc., Aesculap, Inc., Ethicon, Inc., Medtronic Plc, Baxter International, Medline Industries, Inc., Futura Surgicare Pvt. Ltd., CP Medical Corp., Bentley Healthcare Pvt. Ltd., WNDW Medical Inc., GPC Medical Ltd., and others |
Key Market Opportunities | New product launches and R&D Amongst major key Players |
Key Market Drivers |
|
The bone wax market has a predicted CAGR of 2.90% during the forecast period of 2022-2030.
The hurdles are strict regulations, availability of better alternatives, and side-effects that can deter the bone wax market growth.
Bone wax market has key players like Aesculap, Inc., Ethicon, Inc., GPC Medical Ltd., Medtronic Plc, ABYRX, Inc., Wound Management Technologies, Inc., Medline Industries, Inc., Baxter International, CP Medical Corp., Futura Surgicare Pvt. Ltd., WNDW Medical Inc., Bentley Healthcare Pvt. Ltd., and others.
The Americas would lead the global market.
The Asia Pacific market would be the fastest-growing.
Key Questions Answered
Why Choose Market Research Future?